Intravenous administration of ferric derisomaltose is associated with a higher incidence of infusion reactions than ferric carboxymaltose, and unaffected by dilution volume
Internal Medicine Journal · 2025
DOI: 10.1111/imj.70100 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Internal Medicine Journal, 2025. Verfasst von Sarah Lucas und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Northern Health, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Ferric Compounds, Maltose, Drug Hypersensitivity. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
The incidence of and risk factors for infusion‐related reactions to intravenous iron formulations remains poorly characterised. This study aimed to compare the rates of infusion reactions in patients receiving ferric derisomaltose (FDI) compared to ferric carboxymaltose (FCM), as well as across different dilutions of FDI.
Aims
To compare the rates of infusion reactions in patients receiving ferric derisomaltose (FDI) compared to ferric carboxymaltose (FCM), as well as across different dilutions of FDI.
Methods
This was a single tertiary centre retrospective matched cohort study of patients who received FDI or FCM between January 2022 and May 2023. Reactions were classified as Fishbane or hypersensitivity and characterised by severity using the Ring and Messmer classification.
Results
A total of 660 patients (330 age‐ and sex‐matched patients who received FDI and FCM, respectively) were included. Hypersensitivity reactions occurred in 34 of 330 (10.3%) patients receiving FDI infusions compared to eight of 330 (2.4%) patients receiving FCM (odds ratio (OR), 4.62 (95% confidence interval (CI), 2.10–9.78), P < 0.0001). All reactions to FCM and FDI were classified as mild to moderate except for one grade III reaction to FDI. There was no difference in the rate of reaction between patients receiving FDI diluted in 100 mL (18/165) compared to 250 mL (16/165) sodium chloride (OR, 1.14 (95% CI, 0.55–2.27), P = 0.86). A history of a reaction to an alternative iron formulation was associated with increased risk of infusion reactions (OR, 3.55 (95% CI, 0.67–18.97), P = 0.14) and increasing age was associated with reduced risk (OR, 0.96 (95% CI, 0.94–0.99), P = 0.02).
Conclusion
Patients receiving FDI had a significantly higher risk of mild infusion reactions compared to those receiving FCM, with no difference across different dilution volumes of FDI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Northern Health, Melbourne, Victoria, Australia.
- Research Development and Governance Unit, Northern Health, Melbourne, Victoria, Australia.
- Department of Haematology, Northern Health, Melbourne, Victoria, Australia.
- Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia.
ORCID-Profile: Sarah Lucas, Teresa Leung, Mayur Garg
Zitieren
APA
Lucas, S., Chauhan, A., Hurley, C., Xu, C., Yu, C., Tan, K., Taylor, S., Suleiman, M., Leung, T., & Garg, M. (2025). Intravenous administration of ferric derisomaltose is associated with a higher incidence of infusion reactions than ferric carboxymaltose, and unaffected by dilution volume. Internal Medicine Journal. https://doi.org/10.1111/imj.70100
Vancouver
Lucas S, Chauhan A, Hurley C, Xu C, Yu C, Tan K, et al. Intravenous administration of ferric derisomaltose is associated with a higher incidence of infusion reactions than ferric carboxymaltose, and unaffected by dilution volume. Internal Medicine Journal. 2025. doi:10.1111/imj.70100
BibTeX
@article{Lucas2025,
author = {Lucas, Sarah and Chauhan, Ayushi and Hurley, Ciaran and Xu, Calvin and Yu, Catherine and Tan, Katrina and Taylor, Sarah and Suleiman, Mani and Leung, Teresa and Garg, Mayur},
title = {Intravenous administration of ferric derisomaltose is associated with a higher incidence of infusion reactions than ferric carboxymaltose, and unaffected by dilution volume},
journal = {Internal Medicine Journal},
year = {2025},
doi = {10.1111/imj.70100}
}
EUVIMED